Compare Tempo Scan Pacific Tbk. (TSPC) vs Mizuho Leasing Indonesia Tbk. (VRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempo Scan Pacific Tbk. vs Mizuho Leasing Indonesia Tbk. — how do they compare? Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume), while Mizuho Leasing Indonesia Tbk. trades at Rp76 (market cap 432.24B, 286.8K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 27× Mizuho Leasing Indonesia Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (429.7K versus 286.8K). Which is the better fit depends on your goals.
| TSPC | VRNA | |
|---|---|---|
Market Cap | 11.68T | 432.24B |
Volume | 429.7K | 286.8K |
Lot | 4.3K | 2.87K |
Turnover | 1.11B | 22.19M |
Average Price | 2,591.65 | 77.35 |
Value | 1.11B | 22.19M |
Indicative Equilibrium Price | 2,580 | 76 |
Indicative Equilibrium Volume | 100 | 5K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →About Mizuho Leasing Indonesia Tbk.
PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.
Read more on VRNA →
